 The purpose of this study is to find out whether rivaroxaban is safe and effective to use in children age newborn to less than 6 months and how long it stays in the body and how it is used in the body. Safety will be assesed by looking at the incidence and types of bleeding events. There will also be a check for worsening of blood clots. 